BACKGROUND
B virus is an infectious disease endemic to Old World macaque monkeys, a species commonly used in biomedical research. Similar to herpes simplex virus, B virus is one of many non-human primate herpesviruses and the only one known to be pathogenic to humans. Infected macaques are generally asymptomatic or display only mild symptoms. B virus' effect in humans, however, is more dire. Infection can lead to rapid onset encephalomyelitis (Weber & Rutala, 2001) with an estimated mortality rate of 70% to 80% (Huff & Barry, 2003) . Although only 40 reports of B virus in humans have been noted, the high mortality rate makes B virus a serious threat to non-human primate handlers. This threat and the fact that an estimated 80% to 100% (Huff & Barry, 2003) 
APARADIGM SHIFTING CASE
The first known transmission ofB virus to a human occurred in 1932. A group of cases associated with the development of polio vaccine occurred in the 1950s, and another cluster associated with a Florida laboratory arose in the 1980s. B virus gained more attention in 1997 when the first known transmission of the disease via a mucocutaneous exposure occurred, indicating a higher degree of infectivity than previously thought. In this case, an animal worker with a history of an ocular exposure to macaque body fluids went to an emergency room for a red and swollen eye. Treatment consistent with B virus protocols was not initiated until 2 weeks later when the worker returned with worsened symptoms. Despite treatment with IV antivirals and an apparent remission, the worker developed encephalomyelitis and died approximately 42 days after the initial exposure ("Fatal Cercopithecine," 1998) .
This case galvanized infectious disease and occupational health experts, because B virus was not thought to be transmitted to humans via mucocutaneous exposure without injury. As a result, an expert group convened and established new recommendations for humans working with non-human primates.
B virus has been transmitted via direct contact through bites, scratches, and mucosal splashes, but also through contact with cages, instruments used on monkeys, and handling of tissue lines that come into contact with non-intact skin or mucus membranes. The severity of injury does not correlate with the risk of infection; even insignificant exposures have resulted in transmission (Hilliard, 1996) . Lower-risk exposures that do not receive aggressive washing of the site or flushing of a mucous membrane carry an increased risk of B virus transmission. All nonhuman primate handlers should be instructed to view all macaques as potential sources of B virus, and to use .proper personal protective equipment (PPE) and handling techniques (Huff & Barry, 2003) .
PREVENTIVE MEASURES
The best way to prevent transmission of B virus infection is by preventing monkey bites. Prevention measures include PPE and staff training. Training on PPE, safe handling of monkeys, first aid for exposures, reporting of exposures, and the nature and early symptoms of B virus should be conducted during pre-placement and thereafter on an annual basis ("Guidelines for Prevention," 1987).
Ocular protection is perhaps the most important item of PPE for animal handlers because of the number of cases associated with eye splashes (NIOSH,' 1999) . Ocular protection should be mandatory for entering containment areas, conducting captures, and transporting caged macaques ("Fatal Cercopithecine," 1998), and should meet or exceed established American National Standards Institute guidelines for splash protection (NIOSH, 2001) . Face shields and eyeglasses are not sufficient (NIOSH, 1999) . If face shields are used as secondary protection, they must be the type that prevents droplets from running into the eyes and mucous membrane exposure around the sides.
BVirus Exposure Prophylaxis
Prophylaxis Recommended • Deep puncture bite. • Post-cleaning culture positive for Bvirus. • Any inadequately cleansed skin exposure (with loss of skin integrity) or mucosal exposure. • Skin exposure with loss of skin integrity or mucosal exposure to an ill, immunocompromised, or lesioned macaque. • Needlestick associated with tissue orfluid from the nervous system, lesions suspicious for Bvirus, eyelids, or mucosa. • Puncture or laceration after exposure to objects that are (1) contaminated either with fluid from monkey oral orgenital lesions, or with nervous system tissues; or (2) known to contain Bvirus.
Prophylaxis Considered
• Mucosal splash orskin laceration that has been adequately cleansed.
• Needlestick involving blood from an ill or immunocompromised macaque.
• Puncture or laceration occurring after exposure to (1) objects contaminated with body fluid (other than that from a lesion), or (2) potentially infected cell culture.
Prophylaxis Not Recommended
• Skin exposure in which the skin remains intact.
• Exposure associated with a non-macaque species of non-human primates. Cohen etal. (2002) .
Other PPE may include disposable head covers, gowns, gloves, and shoe covers.
Facilities with macaques should have written policies, procedures, and protocols for monkey bites readily accessible. Relationships between the laboratory staff and occupational health clinicians, and between occupational health clinicians and emergency room personnel should be arranged and fostered so if an exposure occurs, proper assessment and therapy can be provided promptly. Workers should carry alert cards with them at all times to help ensure appropriate care is given if they arrive in a disoriented state and are unable to give a history of working with macaques. A copy of this card is available at www2.gsu.edu/-wwwvir/PDFs/ 2004%20Medical%20Alert.pdf.
TREATMENT
After an exposure occurs, the first few minutes are the most critical period to prevent transmission (Cohen, 2(02). Workers with exposures should be trained to clean wounds 386 before taking any other step, including reporting. Eyes or mucous membranes potentially exposed to B virus should be irrigated immediately with water or saline solution for 15 minutes. Exposed skin should be washed immediately with povidone iodine, chlorhexidine, or detergent soap for 15 minutes. Only after proper cleaning should any other steps be taken (Cohen et al., 2002) .
Health care providers caring for workers with potential B virus exposures should collect a thorough database of information. In addition to a typical health history, the clinician should inquire about: • Animal's current health status. • Time, source, and type of exposure. • Adequacy of cleansing after exposure.
• Species of primate involved in the exposure. • Safety procedures in place at time of exposure. • Type of research for which the animal is being used.
. Regardless of a report of adequate cleansing, cleansing for 15 minutes with the appropriate material should be repeated while under observation of the clinician (Cohen et aI., 2002) .
Exposures to B virus are triaged in a method similar to bloodbome pathogen exposures. The decision to provide prophylaxis is based on certain variables: • Source of exposure. • Wound type, depth, and location. • Timeliness and adequacy of first aid.
Types of exposures with a higher risk of viral transmission are deep puncture wounds; inadequately cleaned wounds; and wounds sustained on the face, neck, or thorax (Cohen et aI., 2002) . Recommendations for post-exposure prophylaxis developed by the B Virus Working Group are listed in the Sidebar.
It is important to realize that no existing data proves prophylaxis after exposure is effective in humans. However, animal studies and the fact that there have been no cases of B virus in humans when given prophylaxis after exposure suggests that it may be effective. The B Virus Working Group recommends 1 g of valacyclovir three times a day for adults, excluding pregnant women. An alternative is 800 mg of acyclovir five times a day. Prophylaxis should be given as soon as possible after exposure and first aid (cleaning), preferably within a few hours. It is discontinued if symptoms of B virus appear. At that point, treatment with intravenous antivirals and hospitalization must be initiated (Cohen et al., 2002) .
Cultures of the wound and, if possible, the monkey involved in the exposure should be sent for testing for B virus. They should not be sent to a regular laboratory, but to one of three labs in the country equipped for B virus testing. This is because B virus is classified as a Biosafety Level 4 agent. Procedures for collecting and sending samples are available through the National B Virus Resource Center and may be downloaded from www2.gsu.edul-wwwvir/PDFs/ Sample_Collection_(BV-1 ).pdf.
AAOHNJOURNAL
Clinical Rounds: Hospital Link CONCLUSIONS A complete discussion of B virus is beyond thescopeofthiscolumn andthe reader is directed to the references for more complete information. Although B virus is a serious risk for non-human primatehandlers, it is important to note that with the number of workers who handlemacaques dailyand the number of bites that occur yearly, actual transmission of B virus is still considered rare. However, because many cases are associated with"trivial"exposures, and human mortality, should a case occur, is 80% (Cohen et al., 2002) , medical centers need to take the potential for B virusexposure seriously.
